Upgrade to SI Premium - Free Trial

Schrodinger Inc. (SDGR) Misses Q1 EPS by 12c, Revenues Beat

May 13, 2020 7:03 AM

Schrodinger Inc. (NASDAQ: SDGR) reported Q1 EPS of ($0.34), $0.12 worse than the analyst estimate of ($0.22). Revenue for the quarter came in at $26.2 million versus the consensus estimate of $22.37 million.

First Quarter Financial Results

“The first quarter was marked by a significant milestone for Schrödinger with the completion of our successful IPO, which is a credit to our employees and our commitment to advancing the science underlying our platform,” said Schrödinger CEO Ramy Farid, Ph.D. “We are proud of what our team has accomplished, and we will continue to innovate as we work towards our mission of improving human health and quality of life by transforming the way therapeutics and materials are discovered.”

“We are very pleased with our performance in the first quarter of 2020. Our revenue growth reflects the continuing trend of increased adoption of our physics-based solutions by pharmaceutical, biotechnology, and industrial companies,” said Schrödinger CFO Joel Lebowitz. “This quarter we also continued to invest heavily in research and development to advance our wholly-owned programs and the science underlying our platform.”

For earnings history and earnings-related data on Schrodinger Inc. (SDGR) click here.

Categories

Corporate News Earnings Management Comments

Next Articles